Therefore, the NLRP3-IL-1β pathway is essential in the development of obesity-related complications and its downregulation was demonstrated to decrease the expression of pro-inflammatory CKs, inflammatory processes, and fibrosis within the AT [106,107]. Here, IL1B is linked to obesity disorder.